ORIGINAL RESEARCH article
Front. Med.
Sec. Obstetrics and Gynecology
This article is part of the Research Topic25 Years of 21st Century MedicineView all 29 articles
The diagnostic value of serum inflammation, coagulation and tumor indexes in differentiating stage Ⅲ and Ⅳ ovarian endometriotic cysts
Provisionally accepted
- Jinshan Hospital, Fudan University, Shanghai, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Ovarian endometriotic cysts (OEC) are classified into early (I-II) and advanced (III-IV) stages. Stage IV OEC is characterized by severe adhesions and anatomical distortion that complicate surgical management. Accurate preoperative differentiation between stage III and IV OEC is crucial for optimizing surgical planning and patient outcomes. Objective: This study aimed to investigate the diagnostic value of serum inflammatory, coagulation, and tumor markers in differentiating stage III from stage IV OEC. Methods: This retrospective study analyzed 205 patients with histopathologically confirmed stage III (n=132) and stage IV (n=73) OEC who underwent surgical treatment between January 2013 and December 2019. Patients were divided into training (70%) and test (30%) cohorts. Inflammatory markers, coagulation parameters, and tumor markers were evaluated. Multivariate logistic regression identified independent predictors, and a nomogram was constructed to predict stage IV disease. Results: Stage IV patients demonstrated significantly elevated platelet-to-lymphocyte ratio (PLR), thrombin time, fibrinogen (FIB) levels, and carbohydrate antigen 125 (CA125) concentrations compared to stage III patients. Multivariate analysis identified PLR, FIB, and CA125 as independent predictors of stage IV OEC. The combined nomogram (PLR, FIB, and CA125) achieved superior diagnostic performance with an AUC of 0.81 (95% CI: 0.75-0.88) in the training cohort and 0.78 (95% CI: 0.65-0.91) in the test cohort, outperforming individual biomarkers. Conclusions: The integration of PLR, FIB, and CA125 provides a practical, non-invasive, and cost-effective approach for preoperative differentiation of stage III and IV OEC, which potentially facilitates improved surgical planning and personalized patient management.
Keywords: endometriosis staging, integration of PLR, FIB, and CA125, nomogram, Ovarian endometriotic cysts, stage
Received: 27 Oct 2025; Accepted: 22 Dec 2025.
Copyright: © 2025 Lu, Liu and Xing. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Yan-Yan Xing
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.